|
(V513) |
Inferior vena cava diameter in patients admitted for acute decompensated heart failure is a predictor of all-cause mortality |
| |
|
A. Jobs, K. Brünjes, A. Katalinic, V. Babaev, M. Reppel, H. Thiele (Lübeck) |
|
|
Diskussion |
|
(V514) |
Low procalcitonin indicates stable disease after hospitalisation for decompensated systolic heart failure |
| |
|
S. Brenner, C. Reichert, G. Güder, D. Berliner, M. Breunig, C. Morbach, G. Ertl, C. E. Angermann, S. Störk (Würzburg, Hannover) |
|
|
Diskussion |
|
(V515) |
Prognostic impact of atrial fibrillation in acute myocardial infarction complicated by cardiogenic shock - a substudy of the IABP-SHOCK II trial |
| |
|
S. de Waha, K. Schöne, G. Fürnau, S. Desch, I. Eitel, J. Pöss, C. Eitel, R. R. Tilz, G. C. Schuler, K. Werdan, S. Schneider, T. Ouarrak, U. Zeymer, H. Thiele (Lübeck, Leipzig, Halle/Saale, Ludwigshafen) |
|
|
Diskussion |
|
(V516) |
Concomitant implantation of IMPELLA on top of ECMO improves survival of patients with cardiogenic shock: a retrospective, multicenter, propensity matched study |
| |
|
C. Schulte, F. Pappalardo, M. Pieri, B. Schrage, R. Contri, G. Söffker, T. Greco, K. Müllerleile, A. Colombo, K. Sydow, M. De Bonis, F. Wagner, S. Blankenberg, A. Zangrillo, D. Westermann (Hamburg; Milan, IT) |
|
|
Diskussion |
|
(V517) |
Efficacy and Safety of Glyoprotein IIb/IIIa Receptor Antagonists in Patients with Infarct-Related Cardiogenic Shock |
| |
|
A. Abdin, I. Eitel, G. Fürnau, S. Desch, G. C. Schuler, K. Werdan, U. Zeymer, H. Thiele (Lübeck, Leipzig, Halle/Saale, Ludwigshafen) |
|
|
Diskussion |
|
(V518) |
Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction – The Randomized SHOCK-COOL Pilot Trial |
| |
|
G. Fürnau, J. Beck, S. Desch, I. Eitel, S. Erbs, N. Mangner, K. Fengler, M. Sandri, G. C. Schuler, H. Thiele (Lübeck, Leipzig) |
|
|
Diskussion |